1 Introduction
1.1 What Is This Report About?
1.2 Hormonal Disorders Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Hormonal Disorders Market, Germany
2.1 Hormonal Disorders Market, Germany, Revenue ($m), 2024-2036
2.1.1 Thyroid Function Tests Market, Germany, Revenue ($m), by Segment, 2024-2036
2.2 Hormonal Disorders Market, Germany, Volume (Units), 2024-2036
2.2.1 Thyroid Function Tests Market, Germany, Volume (Units), by Segment, 2024-2036
2.3 Hormonal Disorders Market, Germany, Average Price ($), 2024-2036
2.4 Hormonal Disorders Market, Germany, Company Share by Revenue ($m), 2025
3 Hormonal Disorders Market Pipeline Products
3.1 Hormonal Disorders Market Pipeline Products
3.2 Hormonal Disorders - Pipeline Products by Stage of Development
3.3 Hormonal Disorders - Pipeline Products by Segment
3.4 Hormonal Disorders - Pipeline Products by Territory
3.5 Hormonal Disorders - Pipeline Products by Regulatory Path
3.6 Hormonal Disorders - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in Germany, Hormonal Disorders Market
4.1 Siemens Healthineers AG
4.1.1 Company Overview
4.2 Beckman Coulter Inc
4.2.1 Company Overview
4.3 Roche Diagnostics International Ltd
4.3.1 Company Overview
4.4 Abbott Laboratories
4.4.1 Company Overview
4.5 Ortho Clinical Diagnostics Holdings Ltd (Inactive)
4.5.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Oct 13, 2025: EASL CPGs Dissemination And Implementation Programme
5.2 Financial Announcements
5.2.1 Feb 05, 2026: Siemens Healthineers Announces Q1 Results for Fiscal Year 2026
5.3 Government and Public Interest
5.3.1 Jan 12, 2026: Eckert & Ziegler to Attend J.P. Morgan Healthcare Conference
5.4 Product News
5.4.1 Feb 17, 2026: BioMed X Launches XFem Labs Women's Health Accelerator With Pitch Event
5.4.2 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
5.5 Strategy And Business Planning
5.5.1 Nov 11, 2025: Samsung Active Asset Management Launches KoAct US Biohealthcare Active ETF Benchmarking the Solactive US Biohealthcare Index
5.5.2 Oct 22, 2025: HMI Medical Expands Imaging Services in Singapore
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the Analyst Consulting
6.3 Contact Us
6.4 Disclaimer
List of Tables
Table 1: Hormonal Disorders Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 2: Thyroid Function Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Table 3: Hormonal Disorders Market, Germany, Volume (Units), 2024-2036
Table 4: Thyroid Function Tests Market, Germany, Volume (Units), 2024-2036
Table 5: Hormonal Disorders Market, Germany, Average Price ($), 2024-2036
Table 6: Hormonal Disorders Market, Germany, Company Share by Revenue ($m), USD Constant, 2025
Table 7: Hormonal Disorders Market Pipeline Products
Table 8: Hormonal Disorders - Pipeline Products by Stage of Development
Table 9: Hormonal Disorders Companies - Pipeline Products by Stage of Development
Table 10: Hormonal Disorders - Pipeline Products by Segment
Table 11: Hormonal Disorders - Pipeline Products by Territory
Table 12: Hormonal Disorders - Pipeline Products by Regulatory Path
Table 13: Hormonal Disorders - Pipeline Products by Estimated Approval Date
Table 14: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hormonal Disorders Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 2: Thyroid Function Tests Market, Germany, Revenue ($m), USD Constant, 2024-2036
Figure 3: Hormonal Disorders Market, Germany, Volume (Units), 2024-2036
Figure 4: Thyroid Function Tests Market, Germany, Volume (Units), 2024-2036
Figure 5: Hormonal Disorders Market, Germany, Company Share (%), 2025
Figure 6: Hormonal Disorders - Pipeline Products by Stage of Development
Figure 7: Hormonal Disorders - Pipeline Products by Segment
Figure 8: Hormonal Disorders - Pipeline Products by Territory
Figure 9: Hormonal Disorders - Pipeline Products by Regulatory Path
Figure 10: Hormonal Disorders - Pipeline Products by Estimated Approval Date
